Emory is recognized as one of the nation's leading research universities. In fiscal year 2011 Emory received:
$539.7 million in total research funding awards
$511.5 million in health sciences research funding awards
$370.7 million in federal research funding awards, led by the National Institutes of Health with $318.8 million
In 2011, a study in the New England Journal of Medicine named Emory University as the nation's fourth largest contributor to the discovery of new drugs and vaccines by public-sector research institutions.
Emory is a leader in HIV research. More than nine in 10 HIV patients in the United States who are on lifesaving therapy take Emtriva (emtricitabine) or 3TC (lamivudine), both drugs created at Emory. One of the leading vaccine candidates against HIV was developed at the Emory Vaccine Center and the Yerkes National Primate Research Center.
Emory's campus boasts 1.7 million square feet of scientific research space.
Emory's School of Medicine ranked No. 16 nationally in National Institutes of Health grant funding to medical schools ($347.7 million), as of fall 2010.
Neuroscience innovations by Emory faculty include the development of brain mapping to guide deep brain stimulation for the treatment of Parkinson’s and dystonia, and discovery of the gene responsible for fragile X syndrome, the most common cause of inherited mental retardation.
Emory's SIRE and INSPIRE programs award research grants to undergraduates who would like to participate more fully in meaningful research early on in their academic careers.
Emory is one of eight NIH-sponsored Vaccine Evaluation and Trial Units conducting clinical trials for vaccines for infectious diseases, including H1N1 flu.
Emory is a leader in technology transfer, with 27 products in the marketplace and 12 more in human clinical trials. Since 1992, Emory has launched 51 start-up companies and has received a total of $788 million from the commercialization of its technologies.
Emory cardiologists helped develop lifesaving procedures including angioplasty and drug-eluting stents, and newer technologies such as off-pump surgery.
The research partnership between Emory and Georgia Tech includes the No. 2-ranked Wallace H. Coulter Department of Biomedical Engineering, the Georgia Tech-Emory Center for Regenerative Medicine, the Emory/Georgia Tech Predictive Health Institute and the nation's largest NIH-funded research program in nanomedicine.
Emory provides a top 15 work environment for life science postdoctoral research professionals in a 2011 ranking of national academic institutions, according to The Scientist.
The Emory Global Health Institute-China Tobacco Control Partnership is pursuing five new Programs of Excellence in Tobacco Control aimed at helping reduce the burden of tobacco use in China. Emory's Nell Hodgson Woodruff School of Nursing received $8.1 million from the Bill & Melinda Gates Foundation in 2010 for a project designed to improve maternal and newborn survival rates in rural Ethiopia.
Facebook
YouTube
Twitter
iTunes U
Emory Mobile
Google+